Literature DB >> 10714546

Effects of interleukin-15 on in vitro human T cell proliferation and activation.

M S Hasan1, E G Kallas, E K Thomas, J Looney, M Campbell, T G Evans.   

Abstract

Interleukin-15 (IL-15) has been reported to have many activities on T cell populations, including a potential role in improving antigen-specific proliferation in HIV-1 disease. We tested this response in healthy adults by studying the response of T cell populations after stimulation with medium, tetanus, cytomegalovirus (CMV) antigens in cultures from 21 volunteers. IL-15 caused a dose-dependent increase in medium and antigen-induced proliferation. The expansion was due to CD8>natural killer (NK)>CD4 lymphocytes and memory > naive cells. The IL-15-stimulated CD8 cells had increased levels of the activation markers CD69 and DR. The published CMV-induced expression of CD57 on CD8+ cells was increased in CMV seronegative and seropositive subjects by IL-15. IL-15 appears to be a stimulator of T cell populations in healthy adults and may be useful in settings to enhance nonspecific NK activity or antigen-specific CD8 activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10714546     DOI: 10.1089/107999000312513

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  8 in total

1.  Inflammescent CX3CR1+CD57+CD8+ T cells are generated and expanded by IL-15.

Authors:  Stephen R Morris; Bonnie Chen; Joseph C Mudd; Soumya Panigrahi; Carey L Shive; Scott F Sieg; Cheryl M Cameron; David A Zidar; Nicholas T Funderburg; Souheil-Antoine Younes; Benigno Rodriguez; Sara Gianella; Michael M Lederman; Michael L Freeman
Journal:  JCI Insight       Date:  2020-06-04

2.  Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis.

Authors:  L P Carvalho; S Passos; O Bacellar; M Lessa; R P Almeida; A Magalhães; W O Dutra; K J Gollob; P Machado; A Ribeiro de Jesus
Journal:  Parasite Immunol       Date:  2007-05       Impact factor: 2.280

3.  Low dose IL-15 induces snap arming of CD44(low) T lymphocytes in the absence of antigen.

Authors:  David L Tamang; Bryce N Alves; Viki Elliott; Stephanie A Fraser; Doug Redelman; Dorothy Hudig
Journal:  Cell Immunol       Date:  2008-05-16       Impact factor: 4.868

4.  Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infants.

Authors:  Hayley A Gans; Linda L Yasukawa; Cathryn Z Zhang; Rima Hanna Wakim; Mary Rinki; Ross Dehovitz; Ann M Arvin
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

5.  Assessment of the effector function of CMV-specific CTLs isolated using MHC-multimers from granulocyte-colony stimulating factor mobilized peripheral blood.

Authors:  Lorea Beloki; Miriam Ciaurriz; Cristina Mansilla; Amaya Zabalza; Estela Perez-Valderrama; Edward R Samuel; Mark W Lowdell; Natalia Ramirez; Eduardo Olavarria
Journal:  J Transl Med       Date:  2015-05-20       Impact factor: 5.531

Review 6.  Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy.

Authors:  Alti Dayakar; Sambamurthy Chandrasekaran; Suresh V Kuchipudi; Suresh K Kalangi
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

Review 7.  Immunotherapy in People With HIV and Cancer.

Authors:  Camille E Puronen; Emily S Ford; Thomas S Uldrick
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

8.  Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists.

Authors:  Paul S Backhaus; Rūta Veinalde; Laura Hartmann; Jessica E Dunder; Lara M Jeworowski; Jessica Albert; Birgit Hoyler; Tanja Poth; Dirk Jäger; Guy Ungerechts; Christine E Engeland
Journal:  Viruses       Date:  2019-10-03       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.